Literature DB >> 12690424

Agonist-specific coupling of a cloned human alpha1A-adrenoceptor to different second messenger pathways.

Joanna Richardson1, Heather Chatwin, Akira Hirasawa, Gozoh Tsujimoto, Peter D Evans.   

Abstract

The agonist-specific coupling properties of the three cloned human alpha(1)-adrenoceptor subtypes have been compared, when expressed at similar levels in Chinese hamster ovary (CHO) cell lines, using noradrenaline and the (+/-)- meta- and (+/-)- para- structural isomers of octopamine as agonists. The alpha(1A)- and the alpha(1B)-adrenoceptor subtypes coupled to both the release of arachidonic acid and to the accumulation of inositol phosphates, whereas the alpha(1D)-adrenoceptor subtype only coupled effectively to the accumulation of inositol phosphates. The rank order of potencies of the three agonists tested was the same for all the three receptor subtypes when coupled to either signalling pathway: noradrenaline > meta-octopamine > para-octopamine. Meta-octopamine was a partial agonist of the alpha(1A)-adrenoceptor subtype when coupled to arachidonic acid release, whereas para-octopamine was a full agonist of this pathway. In contrast, meta-octopamine was a full agonist at the alpha(1B)-adrenoceptor subtype when coupled to arachidonic acid release, whereas para-octopamine was a partial agonist of this pathway. Neither meta-octopamine, nor para-octopamine acted as full agonists when coupling any of the three alpha(1)-adrenoceptor subtypes to the accumulation of inositol phosphates. Para-octopamine was only a weak partial agonist of this pathway for all three receptor subtypes. The results show that the modulation of arachidonic acid release and inositol 1,4,5-trisphosphate production occurs in both a subtype- and agonist-specific manner for the alpha(1A)-, alpha(1B)- and alpha(1D)-adrenoceptor subtypes. In addition, the alpha(1A)-adrenoceptor exhibits agonist-specific coupling (agonist trafficking) to the different second messenger pathways.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12690424     DOI: 10.1007/s00210-003-0703-x

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  35 in total

Review 1.  Alpha1-adrenergic receptors: new insights and directions.

Authors:  M T Piascik; D M Perez
Journal:  J Pharmacol Exp Ther       Date:  2001-08       Impact factor: 4.030

2.  Selective inhibition of adenylyl cyclase by octopamine via a human cloned alpha 2A-adrenoceptor.

Authors:  C N Airriess; J E Rudling; J M Midgley; P D Evans
Journal:  Br J Pharmacol       Date:  1997-09       Impact factor: 8.739

Review 3.  The elusive nature of intrinsic efficacy.

Authors:  W P Clarke; R A Bond
Journal:  Trends Pharmacol Sci       Date:  1998-07       Impact factor: 14.819

Review 4.  alpha 1-adrenergic receptor subtypes. Molecular structure, function, and signaling.

Authors:  R M Graham; D M Perez; J Hwa; M T Piascik
Journal:  Circ Res       Date:  1996-05       Impact factor: 17.367

Review 5.  Agonist-specific coupling of G-protein-coupled receptors to second-messenger systems.

Authors:  P D Evans; S Robb; T R Cheek; V Reale; F L Hannan; L S Swales; L M Hall; J M Midgley
Journal:  Prog Brain Res       Date:  1995       Impact factor: 2.453

Review 6.  Agonist-receptor efficacy. II. Agonist trafficking of receptor signals.

Authors:  T Kenakin
Journal:  Trends Pharmacol Sci       Date:  1995-07       Impact factor: 14.819

7.  The forgotten serine. A critical role for Ser-2035.42 in ligand binding to and activation of the beta 2-adrenergic receptor.

Authors:  G Liapakis; J A Ballesteros; S Papachristou; W C Chan; X Chen; J A Javitch
Journal:  J Biol Chem       Date:  2000-12-01       Impact factor: 5.157

8.  Identification of two serine residues involved in agonist activation of the beta-adrenergic receptor.

Authors:  C D Strader; M R Candelore; W S Hill; I S Sigal; R A Dixon
Journal:  J Biol Chem       Date:  1989-08-15       Impact factor: 5.157

9.  Molecular characterization of a peripheral receptor for cannabinoids.

Authors:  S Munro; K L Thomas; M Abu-Shaar
Journal:  Nature       Date:  1993-09-02       Impact factor: 49.962

10.  Effector pathway-dependent relative efficacy at serotonin type 2A and 2C receptors: evidence for agonist-directed trafficking of receptor stimulus.

Authors:  K A Berg; S Maayani; J Goldfarb; C Scaramellini; P Leff; W P Clarke
Journal:  Mol Pharmacol       Date:  1998-07       Impact factor: 4.436

View more
  2 in total

Review 1.  Structure-function of alpha1-adrenergic receptors.

Authors:  Dianne M Perez
Journal:  Biochem Pharmacol       Date:  2006-09-16       Impact factor: 5.858

2.  Syntrophin isoforms play specific functional roles in the α1D-adrenergic receptor/DAPC signalosome.

Authors:  John S Lyssand; Kyung-Soon Lee; Mia DeFino; Marvin E Adams; Chris Hague
Journal:  Biochem Biophys Res Commun       Date:  2011-08-09       Impact factor: 3.575

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.